ATC codes:
J04AD03
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis
ICD11 code:
ML32.00
INN
Ethionamide
Medicine type
Chemical agent
List type
Complementary
Formulations
Oral > Solid:
250 mg tablet ;
125 mg tablet (dispersible)
(EMLc)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
The Committee recommended deletion from the EML and/or EMLc of various formulations and strengths of amikacin (injection: 100 mg/2 mL (as sulfate) in 2 mL vial), ethambutol (Oral liquid: 25 mg/mL), ethionamide (tablet: 125 mg), isoniazid (oral liquid: 50 mg/5 mL), linezolid (powder for oral liquid: 100 mg/5 mL), p-aminosalicylic acid (granules: 4 g in sachet) and pyrazinamide (oral liquid: 30 mg/mL), noting that they are not optimal formulations and strengths for tuberculosis treatment.